UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): ~~March~~April 214, 2011

NOBLE MEDICAL TECHNOLOGIES, INC.

(Exact name of registrant as specified in its charter)

Delaware		333-150483		20-0587718
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

4751 Wilshire Boulevard, 3rd Floor, Los Angeles, CA		\90010
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (310) 601-2500 ~~Not Applicable (Former name or former address, if changed since last report.)~~

Not Applicable

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (See General Instruction A.2. below):

o	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

ITEM 1.01

ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT

On ~~March~~April 214, 2011, Noble Medical Technologies, Inc. (the "Company") entered into a ~~Management~~Loan Agreement (“~~Management~~Loan Agreement”) with ~~Trinad~~Cameo ~~Management~~Stars, ~~LLC~~ LLC1 (“~~Trinad~~Cameo”). Pursuant to the ~~Management~~Loan Agreement, ~~Trinad~~the ~~has~~Company agreed to ~~provide~~loan ~~certain management services~~ to Cameo the ~~Company~~principal ~~for~~amount ~~a period~~ of ~~three (3) years~~$250,000 ~~including~~in ~~without~~accordance ~~limitation~~with ~~the sourcing, structuring and negotiation of~~ a ~~potential~~senior ~~business~~promissory ~~combination~~note ~~transaction~~issued ~~involving~~to the Company~~. Under~~ ~~the Management~~on ~~Agreement~~ the ~~Company~~same ~~will~~date ~~compensate Trinad for its services with~~ (i)the ~~a fee equal to $2,080,000, with~~“Note”). ~~$90,000~~Principal ~~payable~~and ininterest ~~advance~~at ofan ~~each consecutive~~annual ~~three-month~~rate ~~period during the term~~ of ~~the~~10% ~~Agreement~~is ~~and with $1,000,000~~ due aton ~~the~~April ~~end~~4, of2012. The ~~the~~Loan ~~3 year term the Management~~ Agreement ~~unless~~provides ~~the~~a ~~Management~~right ~~Agreement is otherwise terminated earlier in accordance with its terms , and (ii) issuance~~ of afirst ~~Warrant~~refusal to ~~purchase 2,000,000 shares of~~ the Company ~~common~~to ~~stock~~consummate ata anFinancing ~~exercise~~(as ~~price~~defined ofin ~~$0.10~~the ~~per~~Loan ~~share (“Warrant”~~Agreement)~~. The~~ ~~Warrant~~with ~~may~~Cameo ~~be exercised in whole~~ or ~~in part by Trinad at~~ any ~~time for a period~~ of ~~ten~~its ~~(10)~~affiliates ~~years. The~~at ~~Management~~anytime ~~Agreement~~while ~~and~~ the ~~Warrant~~principal ~~are~~balance ~~attached~~remains asoutstanding ~~exhibits~~under tothe ~~this report and incorporated herein by reference~~Note.

~~ITEM~~In ~~3.02 UNREGISTERED~~order ~~SALES~~to OFsecure ~~EQUITY~~Cameo’s ~~SECURITIES~~obligations under the Loan Agreement, the Company and Cameo entered into a Security Agreement (the “Security Agreement”), pursuant to which Cameo has granted the Company a security interest in substantially all of its assets.

OnIn ~~March 21~~addition, ~~2011~~Robert Ellin, ~~Noble~~Company’s ~~Medical~~Chief ~~Technologies~~Executive Officer, ~~Inc.~~agreed ~~(the~~to ~~"Company")~~provide ~~entered~~strategic, ~~into~~operational, amanagement ~~Management~~and ~~Agreement~~financial ~~(“Management~~advice ~~Agreement”)~~and ~~with~~consultation ~~Trinad~~to ~~Management~~Cameo, ~~LLC~~and ~~(“Trinad”)~~serve ~~pursuant~~as tothe ~~which~~Co-Chairman of the ~~Company~~Board ~~has~~of ~~agreed~~Cameo. Cameo toissued ~~issue~~Mr. ~~Trinad~~Ellin a ~~Warrant~~five year warrant to purchase 21,~~000~~349,~~000~~851 ~~shares~~common ofunit ~~the~~interests ~~Company~~in ~~common~~Cameo ~~stock~~with at an exercise price of $0.1001 per ~~share (“Warrant”)~~unit. The ~~Warrant~~warrant may be ~~exercised~~cancelled inby ~~whole~~Cameo orif inCameo ~~part~~satisfies byits ~~Trinad~~obligations atunder ~~any~~the ~~time~~Note ~~for~~within asixty ~~period of ten~~ (1060) ~~years. The~~days ~~Warrant~~of ~~was issued without registration under~~ the ~~Securities~~issuance ~~Act~~ of ~~1933~~the Note, asor within ~~amended,~~thirty (~~"1933 Act"~~30) ~~pursuant~~days prior to the ~~exemption~~closing ~~from~~of ~~registration~~a ~~afforded~~pending byequity ~~Section~~transaction of 4(at least $2),000,000 of equity during the ~~1933~~term ~~Act~~of the warrant. NoThe ~~selling~~Loan ~~commission~~Agreement, orthe ~~placement~~Note, ~~agent~~and ~~fees~~the ~~were~~Security ~~paid~~Agreement byare ~~the~~attached ~~Company~~as inexhibits ~~connection~~to ~~with~~this ~~the~~report ~~transaction.~~and incorporated herein by reference

ITEM 9.01

FINANCIAL STATEMENT AND EXHIBITS.

(D)

Exhibits.

10.1	~~10.1~~Loan Agreement, April 4, 2011	~~Management Agreement, dated March 21, 2011~~
10.2	~~10.2~~Form of Note, dated April 4, 2011	~~Form of Warrant, dated March 21, 2011~~
10.3	Form of Security Agreement, dated April 4, 2011

1	Swanky Apps, LLC, who is listed as the borrower under the Loan Agreement is in the process of changing its legal name to Cameo Stars, LLC.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	NOBLE MEDICAL TECHNOLOGIES, INC.
DATED: March 21, 2011	By:	/s/ Tatiana Walker
DATED: April 4, 2011
	By:	/s/ Tatiana Walker
		Tatiana Walker
		Secretary
		Interim Chief Financial Officer

INDEX TO EXHIBITS

EXHIBIT NO.	~~DESCRIPTION OF EXHIBIT~~	DESCRIPTION OF EXHIBIT
10.1		Loan Agreement, April 4, 2011	~~Management Agreement, dated March 21, 2011~~
10.2		Form of Note, dated April 4, 2011	~~Form of Warrant, dated March 21, 2011~~
10.3		Form of Security Agreement, dated April 4, 2011

Filing Compare · Noble Medical Technologies, Inc.